Antirheumatic treatment, disease activity and risk of Staphylococcus aureus bacteraemia in rheumatoid arthritis: a nationwide nested case–control study

OBJECTIVES: To assess how biological disease-modifying antirheumatic drugs (bDMARDs), glucocorticoids and disease activity affect risk of Staphylococcus aureus bacteraemia (SAB) in patients with rheumatoid arthritis (RA). METHODS: In a nationwide cohort of patients with RA from the DANBIO registry,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dieperink, Sabine Sparre, Mehnert, Frank, Nørgaard, Mette, Oestergaard, Louise Bruun, Benfield, Thomas, Petersen, Andreas, Torp-Pedersen, Christian, Glintborg, Bente, Hetland, Merete Lund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756197/
https://www.ncbi.nlm.nih.gov/pubmed/36517186
http://dx.doi.org/10.1136/rmdopen-2022-002636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756197/
https://www.ncbi.nlm.nih.gov/pubmed/36517186
http://dx.doi.org/10.1136/rmdopen-2022-002636

Ejemplares similares